Literature DB >> 216506

Serum cholesterol and squalene in hepatocellular carcinoma.

C Hirayama, Y Yamanishi, T Irisa.   

Abstract

In 15 patients with hepatocellular carcinoma, the serum squalene level is raised significantly in parallel with the serum cholesterol level, though significantly decreased in patients with cholestatic hepatobiliary disease. Serum levels of cholesterol and/or squalene, therefore, could be regarded as a laboratory index reflecting a peculiar sterol metabolism in hepatocellular carcinoma.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 216506     DOI： 10.1016/0009-8981(79)90470-4

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN： 0009-8981            Impact factor:   3.786


  9 in total

1.  Suppression of hypercholesterolemia in hepatoma-bearing rats by cabbage extract and its component, S-methyl-L-cysteine sulfoxide.

Authors:  W Komatsu; Y Miura; K Yagasaki
Journal:  Lipids       Date:  1998-05       Impact factor: 1.880

2.  Polyisoprenoid, cholesterol and ubiquinone levels in human hepatocellular carcinomas.

Authors:  I Eggens; P G Elmberger; P Löw
Journal:  Br J Exp Pathol       Date:  1989-02

3.  Studies on the biosynthesis of polyisoprenols, cholesterol and ubiquinone in highly differentiated human hepatomas.

Authors:  I Eggens; T J Ekström; F Aberg
Journal:  J Exp Pathol (Oxford)       Date:  1990-04

4.  Biliary squalene levels in hepatobiliary disease.

Authors:  Y Nosaka; Y Yamanishi; C Hirayama
Journal:  Gastroenterol Jpn       Date:  1985-08

5.  Sterol and bile acid metabolism after short-term prednisolone treatment in patients with chronic active hepatitis.

Authors:  Y Yamanishi; Y Nosaka; H Kawasaki; C Hirayama; S Ikawa
Journal:  Gastroenterol Jpn       Date:  1985-06

6.  Effects of dietary methionine and cystine on lipid metabolism in hepatoma-bearing rats with hyperlipidemia.

Authors:  M Kawasaki; R Funabiki; K Yagasaki
Journal:  Lipids       Date:  1998-09       Impact factor: 1.880

7.  Effect of KCD-232, a new hypolipidemic agent, on serum lipoprotein changes in hepatoma-bearing rats.

Authors:  T Irikura; K Takagi; K Okada; K Yagasaki
Journal:  Lipids       Date:  1985-07       Impact factor: 1.880

8.  Reduction of hyperlipidemia in hepatoma-bearing rats by dietary fish oil.

Authors:  M Kawasaki; K Yagasaki; Y Miura; R Funabiki
Journal:  Lipids       Date:  1995-05       Impact factor: 1.880

Review 9.  Influence of cholesterol on cancer progression and therapy.

Authors:  Shyamananda Singh Mayengbam; Abhijeet Singh; Ajay D Pillai; Manoj Kumar Bhat
Journal:  Transl Oncol       Date:  2021-03-19       Impact factor: 4.243
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.